Trials / Unknown
UnknownNCT04954534
Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM®
Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM® Phase-I/IIa Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate of Exploratory Efficacy of NEUROSTEM® in Subjects who control group of NEUROSTEM® Phase-I/IIa Clinical Trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | human umbilical cord blood derived mesenchymal stem cells | High dose: 3 x 10\^7cells/2mL 3 repeated intraventricular administrations via an Ommaya Reservoir at 4-week intervals |
Timeline
- Start date
- 2021-07-12
- Primary completion
- 2022-01-31
- Completion
- 2022-06-30
- First posted
- 2021-07-08
- Last updated
- 2021-07-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04954534. Inclusion in this directory is not an endorsement.